Integral Health Status-Based Cluster Analysis in Moderate–Severe COPD Patients Identifies Three Clinical Phenotypes: Relevant for Treatment As Usual and Pulmonary Rehabilitation

International Journal of Behavioral Medicine

Volumn 24, Issue 4, 2017, Pages 571-583

  Peters, Jeannette B ^a   Boer, Lonneke M ^a   Molema, Johan ^a   Heijdra, Yvonne F ^a   Prins, Judith B ^a   Vercoulen, Jan H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adaptation; Clinical phenotypes; Cluster analysis; COPD; Integral health status; Pulmonary rehabilitation

Indexed keywords

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; FEMALE; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; OUTPATIENT; PHENOTYPE; QUALITY OF LIFE;

AGED; CLUSTER ANALYSIS; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTPATIENTS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 85006489521     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-016-9622-3     Document Type: Article

References (31)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015 2015 [cited; Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html
2. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J. Evaluation of CLtIPSEi. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.
3. Beasley R, Weatherall M, Travers J, Shirtcliffe P. Time to define the disorders of the syndrome of COPD. Lancet. 2009;374(9691):670–2.
4. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carre P, Roche N, Initiatives BSC. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. The European respiratory journal. 2010;36(3):531–9.
5. Fingleton J, Weatherall M, Beasley R. Towards individualised treatment in COPD. Thorax. 2011;66(5):363–4.
6. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, Lindblad K, Patel H, Rugman P, Dodson P, Jenkins M, Saunders M, Newbold P, Green RH, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, Brightling CE. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–71.
7. Cho MH, Washko GR, Hoffmann TJ, Criner GJ, Hoffman EA, Martinez FJ, Laird N, Reilly JJ, Silverman EK. Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res. 2010;11:30.
8. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagana X, Gayete A, Pare C, Freixa X, Ferrer J, Ferrer A, Roca J, Galdiz JB, Sauleda J, Monso E, Gea J, Barbera JA, Agusti A, Anto JM, Group P-CS. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. 2011;66(5):430–7.
9. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2005;35(10):1254–62.
10. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Aldington S, Beasley R. Distinct clinical phenotypes of airways disease defined by cluster analysis. The European respiratory journal. 2009;34(4):812–8.
11. Vercoulen JH, Daudey L, Molema J, Vos PJ, Peters JB, Top M, Folgering H. An integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). International journal of behavioral medicine. 2008;15(4):263–79.
12. Verhage TL, Vercoulen JH, van Helvoort HA, Peters JB, Molema J, Dekhuijzen PN, Heijdra YF. Maximal exercise capacity in chronic obstructive pulmonary disease: a limited indicator of the health status. Respiration; international review of thoracic diseases. 2010;80(6):453–62.
13. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59–65.
14. Effing TW, Bourbeau J, Vercoulen J, Apter AJ, Coultas D, Meek P, Valk P, Partridge MR, Palen J. Self-management programmes for COPD: moving forward. Chronic respiratory disease. 2012;9(1):27–35.
15. Nici L, ZuWallack R. American Thoracic Society Subcommittee on integrated care of the CP. An official American Thoracic Society workshop report: the integrated Care of the COPD patient. Proc Am Thorac Soc. 2012;9(1):9–18.
16. Vercoulen JH. A simple method to enable patient-tailored treatment and to motivate the patient to change behaviour. Chronic respiratory disease. 2012;9(4):259–68.
17. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Molken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF, Rehabilitation AETFoP. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.
18. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.
19. Peters JB, Daudey L, Heijdra YF, Molema J, Dekhuijzen PN, Vercoulen JH. Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen clinical screening instrument. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2009;18(7):901–12.
20. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck depression inventory for primary care. Behav Res Ther. 1997;35(8):785–91.
21. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19(8):787–805.
22. Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess. 1985;49(1):71–5.
23. Maille AR, Koning CJ, Zwinderman AH, Willems LN, Dijkman JH, Kaptein AA. The development of the ’Quality-of-life for respiratory illness questionnaire (QOL-RIQ)’: a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med. 1997;91(5):297–309.
24. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–92.
25. Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 1963;58(301):236.
26. Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med. 2011;183(9):1129–37.
27. Rabe KF, Wedzicha JA. Controversies in treatment of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1038–47.
28. Shirtcliffe P, Weatherall M, Travers J, Beasley R. The multiple dimensions of airways disease: targeting treatment to clinical phenotypes. Current opinion in pulmonary medicine. 2011;17(2):72–8.
29. Weatherall M, Shirtcliffe P, Travers J, Beasley R. Use of cluster analysis to define COPD phenotypes. The European respiratory journal. 2010;36(3):472–4.
30. Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, Brightling CE. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186(1):48–55.
31. Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA, Riesco JA, Trigueros JA, Pinera P, Simon A, Lopez-Campos JL, Soriano JB, Ancochea J. Spanish Society of P, thoracic S. Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish society of pulmonology and thoracic surgery. Archivos de bronconeumologia. 2012;48(7):247–57.